← Back to Search

Behavioural Intervention

Floatation Therapy for Methamphetamine Addiction

N/A
Recruiting
Research Sponsored by Laureate Institute for Brain Research, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through completion of the final float session, up to two weeks
Awards & highlights

Study Summary

This trial will explore if a relaxation therapy can help people with amphetamine addiction.

Who is the study for?
This trial is for individuals aged 18-55 with a primary diagnosis of methamphetamine use disorder, who have completed at least two weeks of inpatient treatment and are still enrolled. They must be able to understand English and provide consent. Excluded are those with certain medical conditions, recent caffeine or nicotine use, positive tests for drugs or alcohol, non-correctable vision/hearing issues, or severe psychiatric disorders.Check my eligibility
What is being tested?
The study is testing Floatation-REST—a therapy involving reduced environmental stimulation—against an active comparison condition to see if it's feasible and safe for people being treated for Amphetamine-Type Substance Use Disorder.See study design
What are the potential side effects?
Since this trial involves a non-drug therapy (Floatation-REST), traditional medication side effects aren't expected. However, participants may experience discomfort from the float environment or anxiety due to isolation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through completion of the final float session, up to two weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and through completion of the final float session, up to two weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Side Effects
Secondary outcome measures
Attentiveness on the Positive and Negative Affect Schedule-X (PANAS-X)
Completion Rate
Fatigue on Positive and Negative Affective Schedule- X
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Reduced Environmental Stimulation PoolExperimental Treatment1 Intervention
floating supine in a pool for a prescribed amount of time (1 total session lasting 1 hour)
Group II: Zero Gravity ChairActive Control1 Intervention
floating supine in a zero-gravity chair for a prescribed amount of time (1 total session lasting 1 hour)

Find a Location

Who is running the clinical trial?

Laureate Institute for Brain Research, Inc.Lead Sponsor
50 Previous Clinical Trials
5,245 Total Patients Enrolled

Media Library

Floatation-REST (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05799209 — N/A
Amphetamine Use Disorder Research Study Groups: Reduced Environmental Stimulation Pool, Zero Gravity Chair
Amphetamine Use Disorder Clinical Trial 2023: Floatation-REST Highlights & Side Effects. Trial Name: NCT05799209 — N/A
Floatation-REST (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05799209 — N/A
Amphetamine Use Disorder Patient Testimony for trial: Trial Name: NCT05799209 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies remaining in this trial for participants?

"In accordance with the data provided on clinicaltrials.gov, this investigation is currently in search of participants. This research was brought to life on March 15th 2022 and has since been updated as late as March 22nd 2023."

Answered by AI

Could I possibly qualify for participation in this scientific research?

"To qualify for this medical experiment, subjects should present with an addiction to amphetamines and be between 18-55 years old. A total of 100 participants are being accepted."

Answered by AI

Are participants aged 50 and above allowed to join this trial?

"To be eligible for this clinical trial, prospective participants should range from 18 to 55 years of age. For those younger than 18 or older than 65, there are 315 and 816 studies respectively."

Answered by AI

How many volunteers are contributing to this investigation?

"Affirmative. The clinical trial is attracting participants, according to the data hosted on clinicialtrials.gov. Inception of this project was March 15th 2022 and it has been modified most recently as of March 22nd 2023 with a goal of recruiting 100 patients from one site."

Answered by AI

Who else is applying?

What state do they live in?
Tennessee
What site did they apply to?
Laureate Institute for Brain Research
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
3+

What questions have other patients asked about this trial?

Can I be a study so maybe we can learn more about meth?
PatientReceived 2+ prior treatments

Why did patients apply to this trial?

I am ready to admit and address my addiction. Flotation resonated with me.
PatientReceived no prior treatments
I've used meth for 30+ years and it is a way of life for me. I can't quit even though I want to, I want to be happy and I'm not happy if I don't feel like doing the things I have to do in every day life.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
Floatation-REST in Methamphetamine Use Disorder: A Pilot Study
2022. "Floatation-REST in Methamphetamine Use Disorder: A Pilot Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05799209.
~11 spots leftby Aug 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top